Raymond James Archives - Page 3 of 4

Markets

Raymond James ups HLS Therapeutics to OP; PT to $26 (Canadian)

Raymond James upgraded HLS Therapeutics (TSX:HLS) to “outperform” from “market perform” and raised its price target to $26 (Canadian) from $24 after Pfizer agreed to co-market HLS’s cardiovascular drug...

August 16, 2021

Markets

Raymond James starts Alpha Cognition at OP; PT $2.50 (Canadian)

Raymond James initiated coverage of Alpha Cognition (TSXV:ACOG) with an “outperform” rating and price target of $2.50 (Canadian). The stock closed at 80 cents on June 2. Alpha is in the late stages of clinical...

June 3, 2021

Markets

Raymond James ups Cardiol Therapeutics to OP from MP

Raymond James upgraded Cardiol Therapeutics (TSX:CRDL) to “outperform” from “market perform,” citing enrollment of the first patient in a Phase 2/3 clinical trial investigating the cardioprotective properties of...

April 28, 2021

Markets

Raymond James starts Eupraxia Pharma at OP; PT $13 (Canadian)

Raymond James initiated coverage of Eupraxia Pharmaceuticals (TSX:EPRX) with an “outperform” rating and a $13 price target. The stock closed at $6.21 on April 12. Eupraxia aims to address the growing burden of...

April 13, 2021

Markets

Raymond James ups Perimeter Medical Imaging PT to $6.50 (Canadian) from $3

Raymond James raised its price target for Perimeter Medical Imaging (TSXV:PINK) to $6.50 (Canadian) from $3, citing a deeper look at the artificial intelligence-enabled application of the company’s Optical...

April 5, 2021

Markets

Raymond James starts Skylight Health Group at OP 2; PT $2.25 (Canadian)

Raymond James initiated coverage of Skylight Health Group (TSXV:SHG) with an “outperform (2)” ranting and $2.25 (Canadian) target price. The stock closed at $1.66 on Feb. 23. Skylight operates a large and growing U.S...

February 24, 2021

Markets

Raymond James ups Protech Home Medical PT to $3 (Canadian) from $2.00

Raymond James raised its price target for Protech Home Medical (TSXV:PTQ) to $3 (Canadian) from $2.00, citing an update to its valuation methodology. The stock closed at $2.05 on Jan. 21. Protech is a provider of...

January 22, 2021

Markets

Raymond James starts Protech Home Medical at OP; PT $2 (Canadian)

Raymond James initiated coverage of Protech Home Medical (PTQ-TSXV) with an “outperform” rating and price target of $2 (Canadian). The stock closed at $1.44 on Dec. 14. Protech provides clinical respiratory equipment...

December 15, 2020

Markets

Raymond James starts Perimeter Medical Imaging at OP; PT $3 (Canadian)

Raymond James initiated coverage of Perimeter Medical Imaging AI (TSXV:PINK) with an “outperform” rating and price target of $3 (Canadian). The stock closed at $2.19 on Nov. 6. Perimeter is commercializing its Optical...

November 9, 2020

Developments

Analysts see EAU data broadening utility of Profound Medical’s TULSA-PRO

Analysts for Raymond James and Cowen say two posters to be presented at the European Association of Urology (EAU) virtual conference in mid-July enhance the clinical utility of Profound Medical’s (NASDAQ:PROF;...

June 11, 2020

Tag - Raymond James

Raymond James ups HLS Therapeutics to OP; PT to $26 (Canadian)

Raymond James starts Alpha Cognition at OP; PT $2.50 (Canadian)

Raymond James ups Cardiol Therapeutics to OP from MP

Raymond James starts Eupraxia Pharma at OP; PT $13 (Canadian)

Raymond James ups Perimeter Medical Imaging PT to $6.50 (Canadian) from $3

Raymond James starts Skylight Health Group at OP 2; PT $2.25 (Canadian)

Raymond James ups Protech Home Medical PT to $3 (Canadian) from $2.00

Raymond James starts Protech Home Medical at OP; PT $2 (Canadian)

Raymond James starts Perimeter Medical Imaging at OP; PT $3 (Canadian)

Analysts see EAU data broadening utility of Profound Medical’s TULSA-PRO

General

More